These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16612425)

  • 1. Debate on the paper by David Vlahov & David D. Celentano. Access to AIDS treatment: appropriateness and correctness in the pursuit of good practice.
    Ayres JR
    Cad Saude Publica; 2006 Apr; 22(4):728-30; author reply 730-1. PubMed ID: 16612425
    [No Abstract]   [Full Text] [Related]  

  • 2. Debate on the paper by David Vlahov & David D. Celentano.
    de Lima DB
    Cad Saude Publica; 2006 Apr; 22(4):723; author reply 730-1. PubMed ID: 16612421
    [No Abstract]   [Full Text] [Related]  

  • 3. Debate on the paper by David Vlahov & David D. Celentano. HIV infection, injection drug users and bioethics.
    Palácios M
    Cad Saude Publica; 2006 Apr; 22(4):725-6; author reply 730-1. PubMed ID: 16612423
    [No Abstract]   [Full Text] [Related]  

  • 4. Debate on the paper by David Vlahov & David D. Celentano.
    Vargas EV
    Cad Saude Publica; 2006 Apr; 22(4):722-3; author reply 730-1. PubMed ID: 16612420
    [No Abstract]   [Full Text] [Related]  

  • 5. Debate on the paper by David Vlahov & David D. Celentano.
    Kalichman A
    Cad Saude Publica; 2006 Apr; 22(4):727-8; author reply 730-1. PubMed ID: 16612424
    [No Abstract]   [Full Text] [Related]  

  • 6. Debate on the paper by David Vlahov & David D. Celentano. The double dimension of care and management of injecting drug users living with HIV/AIDS.
    Bastos FI; Boily MC
    Cad Saude Publica; 2006 Apr; 22(4):719-20; author reply 730-1. PubMed ID: 16612418
    [No Abstract]   [Full Text] [Related]  

  • 7. Debate on the paper by David Vlahov & David D. Celentano. Drug users and the HIV/AIDS epidemic: old problems, new perspectives.
    Monteiro S
    Cad Saude Publica; 2006 Apr; 22(4):724-5; author reply 730-1. PubMed ID: 16612422
    [No Abstract]   [Full Text] [Related]  

  • 8. Debate on the paper by David Vlahov & David D. Celentano. The question of technology transfer: how does that apply to Brazilian reality?
    Pechansky F
    Cad Saude Publica; 2006 Apr; 22(4):720-1; author reply 730-1. PubMed ID: 16612419
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers along the care cascade of HIV-infected men in a large urban center of Brazil.
    Hoffmann M; MacCarthy S; Batson A; Crawford-Roberts A; Rasanathan J; Nunn A; Silva LA; Dourado I
    AIDS Care; 2016; 28(1):57-62. PubMed ID: 26291264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brazil celebrates 10 years of universal access to antiretrovirals.
    Morales K
    BMJ; 2006 Nov; 333(7576):989. PubMed ID: 17095776
    [No Abstract]   [Full Text] [Related]  

  • 11. Scaling up HIV treatment, care and support for injecting drug users in Vietnam.
    Maher L; Coupland H; Musson R
    Int J Drug Policy; 2007 Aug; 18(4):296-305. PubMed ID: 17689378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions of people living with HIV/AIDS regarding access to health care.
    Vaswani V; Vaswani R
    Med Law; 2014 Apr; 33(1):64-73. PubMed ID: 24946513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocity and post-trial access for participants in antiretroviral therapy trials.
    Merritt M; Grady C
    AIDS; 2006 Sep; 20(14):1791-4. PubMed ID: 16954719
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial commentary: universal antiretroviral therapy for HIV infection?
    Lundgren JD; Wood R
    Clin Infect Dis; 2013 Sep; 57(6):888-90. PubMed ID: 23759346
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV/AIDS: use of the ICF in Brazil and South Africa--comparative data from four cross-sectional studies.
    Myezwa H; Buchalla CM; Jelsma J; Stewart A
    Physiotherapy; 2011 Mar; 97(1):17-25. PubMed ID: 21295234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings.
    Bartlett JA; Hornberger J; Shewade A; Bhor M; Rajagopalan R
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(4):253-68. PubMed ID: 19721103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting HIV--lessons from Brazil.
    Okie S
    N Engl J Med; 2006 May; 354(19):1977-81. PubMed ID: 16687709
    [No Abstract]   [Full Text] [Related]  

  • 18. Jewish religious ethics mandate access to antiretroviral drugs in developing countries.
    Spira SC; Wainberg MA
    J Int Assoc Physicians AIDS Care (Chic); 2004; 3(1):7-11. PubMed ID: 15112418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virus.
    Khalsa JH; Vocci F
    J Addict Dis; 2008; 27(2):1-10. PubMed ID: 18681186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users.
    Wood E; Hogg RS; Kerr T; Palepu A; Zhang R; Montaner JS
    AIDS; 2005 May; 19(8):837-9. PubMed ID: 15867502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.